Evercore has hired Mark Hanson as a senior managing director in the healthcare group. Hanson, who will be based in the New York office, was most recently a managing director of investment banking in the healthcare group at Barclays since 2008, when Barclays bought the U.S. businesses of Lehman Brothers.
Evercore (NYSE:EVR) announced today that Mark D. Hanson has agreed to join the Firm’s Investment Banking business as a Senior Managing Director in its Healthcare Group and will be based in Evercore’s office in New York.
Mr. Hanson, who will join Evercore in October, was most recently a Managing Director of Investment Banking in the Healthcare Group for Barclays since 2008, when Barclays purchased the U.S. businesses of Lehman Brothers. Prior to that, he was a Managing Director in Lehman Brothers’ Healthcare Group. Mr. Hanson’s recent transactions include advising Amerigroup on its sale to WellPoint, Catamaran on its acquisition of Catalyst, Centene on its acquisition of Ribera Salud, Metropolitan Health Networks on its sale to Humana, Thermo Fisher on numerous transactions including the acquisition of Life Technology and the related divestitures to GE, LabCorp on its acquisition of Medtox, Genoptix on its sale to Novartis, and Allscripts on its acquisition of Eclipsys. Previously Mr. Hanson was a founding partner of Epoch Partners, an investment bank that was successfully built up and sold to Goldman Sachs in 2001. Mr. Hanson began his investment banking career in 1995 at Merrill Lynch.
Roger Altman, Evercore’s Executive Chairman, said, “We are extremely pleased that Mark is joining us to further strengthen our world-class Healthcare team, where he will work closely with other senior members of the group, including Francois Maisonrouge, Matthew McAskin, John Honts and Sean Murphy. Already this year, we have advised AstraZeneca on its unsolicited approach from Pfizer, Shire on its merger with AbbVie, and Sun Pharmaceutical on its acquisition of Ranbaxy Laboratories, among other notable situations.” Ralph Schlosstein, Evercore’s CEO, said, “Healthcare is a large, important industry, and we are committed to delivering the highest quality advice and transaction execution in this sector. Mark’s extensive experience, broad network of relationships, particularly in healthcare services, life science tools and diagnostics, and his reputation for integrity and providing sound, objective advice to some of the most notable companies in his sector, will make him an integral member of our team.”
Mark Hanson said, “I am excited about joining Evercore and building on the Healthcare team’s strong momentum. Evercore’s client focus and philosophy coupled with its leading advisory capabilities and a rapidly expanding equity business provide a great platform to serve clients’ most strategic needs. I look forward to delivering these critical skill sets to the healthcare marketplace.” Mr. Hanson has an MBA from Dartmouth’s Tuck School of Business and a BA from St. Olaf College.
Evercore is a leading independent investment banking advisory firm. Evercore’s Investment Banking business advises its clients on mergers, acquisitions, divestitures, restructurings, financings, public offerings, private placements and other strategic transactions and also provides institutional investors with high quality equity research, sales and trading execution that is free of the conflicts created by proprietary activities. Evercore’s Investment Management business comprises wealth management, institutional asset management and private equity investing. Evercore serves a diverse set of clients around the world from 20 offices in North America, Europe, South America and Asia. More information about Evercore can be found on the Company’s website at www.evercore.com.
Take your pick!
- Buyouts delivers exclusive news and analysis about private equity deals, fundraising, top-quartile managers and more. Get your FREE trial or subscribe now.
- VC Journal provides exclusive news and analysis about venture capital deals, fundraising, top-quartile investors and more. Get your FREE trial or subscribe now.